# PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics

> **NCT05033119** · — · COMPLETED · sponsor: **Ulla Schierup Nielsen** · enrollment: 90 (actual)

## Conditions studied

- Hyperprolactinemia
- Puberty Disorders
- Metabolic Syndrome
- Growth Disorders
- Antipsychotics and Neuroleptics Toxicity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05033119
- **Lead sponsor:** Ulla Schierup Nielsen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05033119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05033119, "PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05033119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*